Cutanea is focused on developing innovative treatments for diverse skin conditions in areas of unsatisfied aesthetic and medical need. Currently we have the following three product development programs in our pipeline:
A cationic antimicrobial peptide in development for the treatment of rosacea.
A novel dermal filler in development for a variety of soft tissue augmentation procedures.
An antiviral therapy in development for the treatment of cutaneous warts.
